Aurobindo Pharma Competitors and Similar CompaniesClear all

Aurobindo Pharma's competitors and similar companies include Siegfried, Vectura Group, Nexelis and BTG.

	Aurobindo Pharma Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa.	Siegfried Siegfried Holding is a company that develops and manufactures drug substances and products.	Vectura Group Vectura Group is a product development company that focuses on drug delivery.	Nexelis Nexelis is an immunology centric provider offering preclinical and clinical specialty laboratory services.	BTG BTG is a biopharmaceutical company.
Founding Date	Founding Date 1986	Founding Date 1873	Founding Date N/A	Founding Date 2015	Founding Date 1980
Type	Type Public	Type Public	Type Subsidiary	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech pharma	Tags Manufacturing & Industrial biotech drug development pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Hyderabad, IN HQ Hyderabad, IN South Brunswick Township, US	Locations Zofingen, CH HQ Nantong, CN Saint Vulbas, FR Hameln, DE Minden, DE Birżebbuġa, MT Barberà Del Vallès, ES see more	Locations Chippenham, GB HQ Saint Quentin Fallavier, FR Gauting, DE München, DE Muttenz, CH London, GB London, GB see more	Locations Laval, CA HQ Charleroi, BE Beijing, CN Marburg, DE Salisbury, GB Indianapolis, US Seattle, US	Locations Be'er Tuvia, IL HQ
Employees	Employees 26,015	Employees 3,886	Employees 502	Employees 1802% decrease	Employees 3441% increase
Financial
Revenue (est.)	Revenue (est.) ₹333.8b (FY, 2026)	Revenue (est.) CHF1.3b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ₹134.9b (FY, 2026)	Cost of goods CHF879.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ₹206.6b (FY, 2026)	Gross profit CHF463.5m (FY, 2025)	Gross profit £2.3m (FY, 2022)	Gross profit N/A	Gross profit N/A
Net income	Net income ₹35b (FY, 2026)	Net income CHF168.4m (FY, 2025)	Net income (£158m) (FY, 2022)	Net income N/A	Net income N/A